Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Zero Based Budgeting focuses your budget on current goals, ensuring every dollar supports progress. Learn how to redefine priorities and monitor progress toward new targets.
26,697 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
On-chain indicators hint XRP may have found a floor, even as price action remains range-bound. Traders are watching f...
Stocks jumped after President Trump signaled possible de-escalation with Iran, fueling a risk-on rally. Yet analysts ...
Palantir shares slid about 5% as a tech-led market pullback intensified, even as the company pursued growth in govern...
Raymond James lifts Valero's price target to $290, arguing sustained refining margins and a structural advantage coul...
Marathon Digital climbs as Bitcoin slides, buoyed by a strategic pivot into enterprise AI compute infrastructure and ...
Amazon isn’t only about Prime or AWS. An underrated reason to invest Amazon stock is its fast-growing advertising bus...
Pi Network advances with protocol upgrades and AI-driven KYC, while the PI token remains volatile amid a cautious mar...
Qualcomm is trading at a discount to peers while building a strong AI silicon footprint. With a June Investor Day and...
LifeStance Health Group stunned the market with a beat-and-raise quarter, sending its stock up roughly 20%. This deep...
Qualcomm exploded higher, gaining about 70% in a single month as it pivots toward AI data-center demand. Investors ar...
A Virginia federal judge denied Zillow and Redfin’s bid to dismiss the FTC antitrust lawsuit, keeping the case alive ...